205 related articles for article (PubMed ID: 30628714)
1. CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway.
Zheng M; Zhou Q; Liu X; Wang C; Liu G
Oncol Rep; 2019 Mar; 41(3):1531-1538. PubMed ID: 30628714
[TBL] [Abstract][Full Text] [Related]
2. E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.
Zhang R; Lu H; Lyu YY; Yang XM; Zhu LY; Yang GD; Jiang PC; Re Y; Song WW; Wang JH; Zhang CC; Gu F; Luo TJ; Wu ZY; Xu CJ
Sci Rep; 2017 Mar; 7():44744. PubMed ID: 28303973
[TBL] [Abstract][Full Text] [Related]
3. CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling.
Ma MZ; Zhuang C; Yang XM; Zhang ZZ; Ma H; Zhang WM; You H; Qin W; Gu J; Yang S; Cao H; Zhang ZG
Neoplasia; 2014 Mar; 16(3):265-78, 278.e1-13. PubMed ID: 24726140
[TBL] [Abstract][Full Text] [Related]
4. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
[TBL] [Abstract][Full Text] [Related]
5. CTHRC1 overexpression promotes ectopic endometrial stromal cell proliferation, migration and invasion via activation of the Wnt/β-catenin pathway.
Lv Y; Zhang L; Ma J; Fei X; Xu K; Lin J
Reprod Biomed Online; 2020 Jan; 40(1):26-32. PubMed ID: 31787549
[TBL] [Abstract][Full Text] [Related]
6. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
7. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex.
Yamamoto S; Nishimura O; Misaki K; Nishita M; Minami Y; Yonemura S; Tarui H; Sasaki H
Dev Cell; 2008 Jul; 15(1):23-36. PubMed ID: 18606138
[TBL] [Abstract][Full Text] [Related]
8. Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
Ye J; Chen W; Wu ZY; Zhang JH; Fei H; Zhang LW; Wang YH; Chen YP; Yang XM
Oncol Rep; 2016 Dec; 36(6):3588-3596. PubMed ID: 27779718
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
10. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
Li J; Qi C; Liu X; Li C; Chen J; Shi M
Sci Rep; 2018 Jul; 8(1):10594. PubMed ID: 30006571
[TBL] [Abstract][Full Text] [Related]
12. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
Bo H; Fan L; Gong Z; Liu Z; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Cao K; Zhang S; Xiong F
Oncol Rep; 2019 Apr; 41(4):2431-2439. PubMed ID: 30816545
[TBL] [Abstract][Full Text] [Related]
13. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
Liu Y; Chang Y; Lu S; Xiang YY
J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
[TBL] [Abstract][Full Text] [Related]
15. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
[TBL] [Abstract][Full Text] [Related]
18. N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.
Liu G; Sengupta PK; Jamal B; Yang HY; Bouchie MP; Lindner V; Varelas X; Kukuruzinska MA
J Biol Chem; 2013 Jul; 288(28):20217-27. PubMed ID: 23703614
[TBL] [Abstract][Full Text] [Related]
19. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling.
Li H; Zhang W; Yan M; Qiu J; Chen J; Sun X; Chen X; Song L; Zhang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):33. PubMed ID: 30678687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
